Aerpio Pharmaceuticals, Inc.
TREATMENT OF OCULAR DISEASE

Last updated:

Abstract:

Disclosed are methods for treating eye diseases or conditions characterized by vascular instability, vascular leakage and neovacularization such as diabetic macular edema, age-related macular edema, choroidal neovascularization, diabetic retinopathy, trauma, ocular ischemia, retinal angiomatous proliferation, macular telangiectasia and uveitis.

Status:
Application
Type:

Utility

Filling date:

24 Jan 2020

Issue date:

23 Jul 2020